Clinical trials of new drugs for Alzheimer disease

Overview of attention for article published in Journal of Biomedical Science, January 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#6 of 1,104)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 34 news stories from 33 outlets.

People with memory loss experience greater than expected levels of forgetfulness and may have difficulty with both short- and…

Treatment advances for Alzheimer’s disease took a quantum leap last year. As of early 2021, there were 126 unique agents in the…

Share on PinterestIn people with Alzheimer’s disease, following the MIND diet can help slow cognitive decline.

On Monday, the Food and Drug Administration (FDA) approved Biogen Pharmaceutical’s $56,000-a-year Alzheimer’s drug, aducanumab.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 30 additional news stories.